- WELL Health Technologies (TSX:WELL) blends traditional healthcare with cutting-edge technology, including telehealth platforms, electronic medical records (EMR), and AI-driven diagnostics
- One of WELL’s most strategic moves was acquiring a majority stake in Circle Medical, a Silicon Valley-based telehealth provider
- The company boasts a perfect 6/6 valuation score, indicating it may be one of the most undervalued small-cap stocks on the TSX
- WELL Health stock (TSX:WELL) last traded at C$4.64
As Canada’s healthcare system grapples with rising demand, aging infrastructure, and the need for more efficient care delivery, small-cap health tech companies are stepping in to reshape the landscape. At the forefront of this transformation is WELL Health Technologies (TSX:WELL)—a digital health powerhouse that wants to redefine how Canadians access medical services.
This content has been prepared as part of a partnership with WELL Health Technologies Corp. and is intended for informational purposes only.
A small-cap stock with big ambitions
WELL Health began as a network of primary care clinics but has evolved into a diversified digital health company. Its strategy blends traditional healthcare with cutting-edge technology, including telehealth platforms, electronic medical records (EMR), and AI-driven diagnostics.
In recent quarters, WELL has reaffirmed its 2025 earnings guidance, projecting revenues between C$1.40 billion and C$1.45 billion. This growth is fueled by both organic expansion and a disciplined acquisition strategy, which has added over C$100 million in annualized revenue since late 2024.
Telehealth expansion: Circle Medical and VirtualClinic+
One of WELL’s most strategic moves was acquiring a majority stake in Circle Medical, a Silicon Valley-based telehealth provider. This deal marked WELL’s entry into the massive US healthcare market, valued at over US$3.6 trillion.
Circle Medical’s platform combines virtual care with in-person services, supported by AI tools that enhance physician decision-making. WELL’s own VirtualClinic+ service has seen explosive growth, with telehealth visits increasing 730 per cent quarter-over-quarter, and over 1,000 practitioners onboarded to meet demand.
Financials and valuation: A hidden gem?
Despite its strong fundamentals, WELL’s stock trades at a significant discount. Analysts estimate its intrinsic value at C$9.81, nearly 50 per cent above current levels. The company boasts a perfect 6/6 valuation score, indicating it may be one of the most undervalued small-cap stocks on the TSX.
Recent earnings show:
- Q2 revenue: C$243.1 million (+42 per cent YoY)
- Adjusted EBITDA: C$30.9 million (+11 per cent)
- Patient visits: 1.4 million (+38 per cent)
These figures reflect not just acquisition-driven growth, but also a robust 21 per cent organic growth rate, underscoring WELL’s operational strength.
What should investors watch?
- Canadian market focus: WELL is streamlining operations to focus more on Canada, where it sees higher returns and lower risk. This includes planned divestitures of some US assets.
- M&A pipeline: With 12 letters of intent (LOIs) in progress, WELL continues to scout for high-margin, tech-enabled healthcare assets.
- AI and EMR integration: WELL’s EMR division saw a 1,212 per cent YoY increase in digital services revenue, signaling strong demand for tech-driven care.
Investor’s corner
WELL Health Technologies is an example of how small-cap companies can lead innovation in Canadian healthcare. With a compelling mix of undervaluation, aggressive growth, and strategic focus on digital health, WELL offers investors a rare opportunity to participate in the future of medicine.
For small-cap investors seeking exposure to healthcare innovation, WELL Health is not just a stock—it’s a story of transformation.
About WELL Health Technologies
WELL is dedicated to tech-enabling healthcare providers. The company’s solutions improve outcomes for over 41,000 healthcare providers between the U.S. and Canada, powering the largest owned and operated healthcare ecosystem in Canada with more than 200 clinics spanning primary care, specialized care and diagnostic services. U.S. operations focus on specialized markets including gastrointestinal, women’s health, primary care and mental health.
WELL Health stock (TSX:WELL) last traded at C$4.64 and has risen nearly 10 per cent since this time last year.
Join the discussion: Find out what the Bullboards are saying about WELL Health Technologies and check out Stockhouse’s stock forums and message boards.
Stockhouse does not provide investment advice or recommendations. All investment decisions should be made based on your own research and consultation with a registered investment professional. The issuer is solely responsible for the accuracy of the information contained herein. For full disclaimer information, please click here.